医学
内科学
苯达莫司汀
奥比努图库单抗
长春新碱
危险系数
滤泡性淋巴瘤
美罗华
切碎
环磷酰胺
强的松
化疗
肿瘤科
诱导化疗
胃肠病学
微小残留病
外科
淋巴瘤
置信区间
白血病
作者
Christiane Pott,Vindi Jurinović,Judith Trotman,Britta Kehden,Michael Unterhalt,M. Herold,Richard van der Jagt,Ann Janssens,Michael Kneba,Jiřı́ Mayer,Moya Young,Christian Schmidt,Andrea Knapp,Tina Nielsen,Helen B. Brown,Nathalie Spielewoy,Chris Harbron,Alessia Bottos,Kirsten Mundt,Robert Marcus,Wolfgang Hiddemann,Eva Hoster
摘要
We report an analysis of minimal residual/detectable disease (MRD) as a predictor of outcome in previously untreated patients with follicular lymphoma (FL) from the randomized, multicenter GALLIUM (ClinicalTrials.gov identifier: NCT01332968) trial.
科研通智能强力驱动
Strongly Powered by AbleSci AI